Sara Bonstein
Chief Financial Officer, Advaxis.
Companies
- Latigo Biotherapeutics, Inc.Board member Aug 6, 2026 to now1
- Xilio Therapeutics, Inc.Board member Oct 21, 2021 to now2
- scPharmaceuticals (United States)Board member Jul 13, 2020 to now3
- INSMED IncChief financial officer Feb 5, 2020 to now4
- ONCOSEC MEDICAL IncChief financial officer Jul 18, 2018 to Jan 21, 20205
- ONCOSEC MEDICAL IncChief operating officer Jul 18, 2018 to Jan 21, 20205
- AdvaxisChief financial officer Mar 31, 2014 to Apr 3, 20186
- AdvaxisBoard member May 2, 2014 to Jul 1, 20147
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- INSMED Inc INSM69,082 shares8$6.9M at $99.21Jun 3, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 3, 2026Sold 2,404 shares at $102.27 of INSMED Inc8
- May 13, 2026Sold 8,272 shares at $116.18 of INSMED Inc9
- Feb 3, 2026Sold 748 shares at $156.34 of INSMED Inc10
- Jan 8, 2026Sold 1,447 shares at $174.17 of INSMED Inc11
- Jan 7, 2026Sold 1,678 shares at $175.07 of INSMED Inc11
- Jan 6, 2026Sold 1,517 shares at $173.33 of INSMED Inc11
- Jan 2, 2026Granted 5,645 shares of INSMED Inc12
- Jan 2, 2026Granted 5,998 shares of INSMED Inc12
- Jul 21, 2025Sold 26,310 shares at $103.03 of INSMED Inc13
- Jul 21, 2025Sold 32,090 shares at $102.38 of INSMED Inc13
- Jul 21, 2025Exercised options 17,100 shares at $34.03 of INSMED Inc13
- Jul 21, 2025Exercised options 15,890 shares at $29.13 of INSMED Inc13
- Jul 21, 2025Exercised options 11,455 shares at $28.88 of INSMED Inc13
- Jul 21, 2025Exercised options 3,443 shares at $26.46 of INSMED Inc13
- Jul 7, 2025Sold 22,181 shares at $96.19 of INSMED Inc14
- Jul 7, 2025Sold 35,583 shares at $95.66 of INSMED Inc14
- Jul 7, 2025Exercised options 13,717 shares at $26.46 of INSMED Inc14
- Jul 7, 2025Exercised options 23,565 shares at $26.43 of INSMED Inc14
- Jul 7, 2025Exercised options 4,362 shares at $24.70 of INSMED Inc14
- Jul 7, 2025Exercised options 6,244 shares at $19.74 of INSMED Inc14
- Jun 23, 2025Sold 8,661 shares at $102.15 of INSMED Inc15
- Jun 23, 2025Sold 49,104 shares at $101.71 of INSMED Inc15
- Jun 23, 2025Exercised options 12,636 shares at $19.74 of INSMED Inc15
- Jun 23, 2025Exercised options 35,253 shares at $18.95 of INSMED Inc15
- Jun 10, 2025Sold 100 shares at $91.66 of INSMED Inc16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARINSMED Inc, Chief financial officer
- 5
- 6SEC EDGARAdvaxis, Chief financial officer
- 7SEC EDGARAdvaxis, Board member
- 8
- 9SEC EDGARForm 4 filed May 15, 2026
- 10SEC EDGARForm 4 filed Feb 4, 2026
- 11SEC EDGARForm 4 filed Jan 8, 2026
- 12SEC EDGARForm 4 filed Jan 6, 2026
- 13SEC EDGARForm 4 filed Jul 23, 2025
- 14SEC EDGARForm 4 filed Jul 9, 2025
- 15SEC EDGARForm 4 filed Jun 25, 2025
- 16SEC EDGARForm 4 filed Jun 12, 2025